MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

By

Phillips-MedisizePhillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark.

Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable diagnostics cancer testing.

The company in the past, though, has touted work it has done for Madison, Wis.–based Exact Sciences (Nasdaq: EXAS), maker of the take-home Cologuard colon cancer test. Cologuard test volume more than doubled to 571,000 tests in 2017.

Get the full story on our sister site Medical Design & Outsourcing. 

More recent news

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].